Indu Bio Products Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 21-06-2024
- Paid Up Capital ₹ 1.59 M
as on 21-06-2024
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -99.95%
(FY 2020)
- Profit -100.19%
(FY 2020)
- Ebitda 97.77%
(FY 2020)
- Net Worth -0.14%
(FY 2020)
- Total Assets -22.91%
(FY 2020)
About Indu Bio Products
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.59 M, as per Ministry of Corporate Affairs (MCA) records.
Indu Puri, Shalini Puri, and Vivek Puri serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PLC062063
- Company No.
062063
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Oct 1994
- Date of AGM
26 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indu Bio Products?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Indu Puri  | Director | 11-Oct-1994 | Current |
| Shalini Puri | Director | 11-Oct-1994 | Current |
| Vivek Puri | Whole-Time Director | 11-Oct-1994 | Current |
Financial Performance of Indu Bio Products.
Indu Bio Products Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 99.95% decrease. The company also saw a substantial fall in profitability, with a 100.19% decrease in profit. The company's net worth dipped by a decrease of 0.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indu Bio Products?
In 2019, Indu Bio Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pom Hydro Energy LimitedActive 11 years 3 monthsIndu Puri, Shalini Puri and 1 more are mutual person
Puri Captive Energy Private LimitedActive 18 years 3 monthsIndu Puri, Shalini Puri and 1 more are mutual person
- Puri Oil Mills Limited.Active 29 years 6 months
Indu Puri, Shalini Puri and 1 more are mutual person
P Mark Edible And Agro Products Private LimitedActive 1 year 7 monthsIndu Puri, Shalini Puri and 1 more are mutual person
- Uhl Hydro Energy Private LimitedActive 3 years 2 months
Indu Puri, Shalini Puri and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indu Bio Products?
Unlock and access historical data on people associated with Indu Bio Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indu Bio Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indu Bio Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
